DR. PARESH TANK

Dr. Paresh Tank is the CEO of PHARMALANE UK Ltd., a prominent Pharmaceutical consultancy based in the UK that specializes in Quality auditing and training. He earned a Ph.D. in Pharmaceutical Operations Management from the French institution Ecole Supérieure Robert de Sorbon, as well as an MSc in Pharmaceutical Sciences from the University of Greenwich in London. With more than 17 years of experience in the pharmaceutical industry, Dr. Tank has mostly dedicated his professional career to the Quality department, where he has also conducted over 300 quality audits of pharmaceutical companies as a Lead Auditor across more than 40 countries. His efforts ensured that medicines adhere to the highest standards, thereby protecting communities around the globe. Prior to his role as CEO, he managed PHARMALANE’s global Quality and Operations team for four years, leading a team of global auditors and consultants.
Since taking on the role of CEO, PHARMALANE UK has witnessed remarkable growth, acquiring total 900 global pharmaceutical companies as clients from over 100 countries. The company operates offices in both the UK and India, employing over 40 full-time employees and over 150 auditors/ consultants based globally. Beyond its commercial success, PHARMALANE has gained a strong reputation in the industry as one of the highly recommended Quality Auditing consultancies in a short period, due to its high-quality services and cost-effective pricing.
Under the leadership of Dr. Tank, the company has also received the ‘Pharma Supplier of the year’ award by PHARMA INDUSTRY AWARDS UK 2026 and ‘Global Inspirational Award 2024’ at the House of Lords, London and is consistently ranked among the leading pharmaceutical consultancies worldwide. Additionally, PHARMALANE was also a finalist in the ‘Pharma Industry Awards UK 2025,’ competing with some of the top companies in the sector.
Dr. Tank’s achievements demonstrate excellence, integrity, and significant global influence. He combines effective business leadership with a commitment to patient safety, affordability, and quality. Accomplishing these milestones in his thirties positions him as an outstanding candidate for the 40 under 40 award.